Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2400300	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2024-11-14	Gan & Lee Pharmaceuticals	view
CYSB2400288	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2024-11-05	Gan & Lee Pharmaceuticals	view
CYSB2400282	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2024-10-26	Gan & Lee Pharmaceuticals	view
CYSB2400224	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-08-29	Gan & Lee Pharmaceuticals	view
CYSB2400140	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals	view
CYSB2400139	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals	view
CYSB2400141	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals	view
CYSB2400073	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2024-03-18	Gan & Lee Pharmaceuticals	view
CYSB2400040	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals	view
CYSB2400041	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals	view
CYSB2300234	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-12-21	Gan & Lee Pharmaceuticals	view
CXSB2300051	GZR18	GZR-18	Injection	Biological Products(1)	Supplementary Application	2023-05-11	Gan & Lee Pharmaceuticals	view
CXSL2300316	GLR1023注射液	GLR-1023	Injection	Biological Products(3.3)	New Drug Application	2023-05-07	Gan & Lee Pharmaceuticals	view
CYSB2300084	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2023-04-19	Gan & Lee Pharmaceuticals	view
CYSB2300079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-04-05	Gan & Lee Pharmaceuticals	view
CYSB2300078	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-04-05	Gan & Lee Pharmaceuticals	view
CXSB2300028	GZR18	GZR-18	Injection	Biological Products(1)	Supplementary Application	2023-03-31	Gan & Lee Pharmaceuticals	view
CXSL2300145	GLR1027注射液	GLR-1027	Injection	Biological Products(3.3)	New Drug Application	2023-02-22	Gan & Lee Pharmaceuticals	view
CYSB2300032	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2023-02-09	Gan & Lee Pharmaceuticals	view
CYSB2200233	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2022-09-23	Gan & Lee Pharmaceuticals	view